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Introduction. The value of contact force information for ablation of LA anterior line is unknown. In a prospective randomized
clinical trial, we investigated if informationon contact force during left atrial (LA) anterior line ablation reduces total radiofrequency
time and results in higher rates of bidirectional line block in patients undergoing pulmonary vein isolation (PVI) plus substrate
modification. Methods. We included patients with indication for pulmonary vein isolation (PVI) and additional substrate
modification. For LA anterior line ablation, patients were randomized to contact force information visible (n=35) or blinded
(n=37). Patients received contrast enhanced cardiac magnetic resonance imaging (cMRI) before and 3-6 months after ablation to
visualize the LA anterior line. Primary endpoint was radiofrequency time to achieve bidirectional line block. Secondary endpoints
were completeness of the LA anterior line on cMRI, distribution of contact force, procedural data, adverse events, and 12 months
success rate. Results. In 72 patients (64±9 years, 68% male), bidirectional LA anterior line block was achieved in 70 (97%) patients.
Radiofrequency time to bidirectional block did not differ significantly across groups (contact force information visible 23±18min
versus contact force information blinded 21±15min, p=0.50). The LA anterior line was discernable on cMRI in 40 patients (82%)
without significant differences across randomization groups (p=0.46). No difference in applied contact force was found depending
on cMRI line visibility. Twelve-month success and adverse event rates were comparable across groups. Conclusion. Information on
contact force does not significantly improve the ablation of LA anterior lines. Clinical Trial Registration. The trial was registered at
http://www.clinicaltrials.gov by identifier: NCT02217657.
1. Introduction
Catheter ablation of atrial fibrillation (AF) has evolved as
a guideline recommended therapeutic option for patients
with this condition. Whereas wide area circumferential
pulmonary vein isolation (PVI) comprises the standard
approach, selected patients require additional left atrial (LA)
linear lesions [1]. By applying LA linear lesions, the goal
is to achieve bidirectional conduction block, as incomplete
block predisposes to the development of atypical atrial flutter.
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However, depending on the LA anatomy, bidirectional block
of the anterior line can only be achieved in 60% to 86% [2, 3].
Preclinical research showed that appropriate contact force
between the ablation catheter tip and the target tissue is a key
contributor to effective lesion formation [4, 5]. Insufficient
contact may result in an ineffective lesion, leading to arrhyth-
mia recurrence, whereas excessive contact force may result
in tissue damage and possibly life threatening complications
[5]. In multicenter clinical trials, PVI using contact force
sensing catheter technology resulted in a reduced rate of
immediate, intraprocedural pulmonary vein reconnection
[6], and reduced rates of AF recurrence during follow-up [7].
However, the benefit of using contact force sensing catheter
technology is unclear for the formation of LA linear lesions.
Thus, in our study, we included patients with persistent
AF or AF recurrence after a first PVI and randomized them
to receive a LA anterior line ablation using either visible or
blinded contact force sensing information. Beyond measures
of procedural success, we systematically obtained cardiac
magnetic resonance imaging (cMRI) to visually assess the
ablation success.
2. Methods
2.1. Study Cohort. Patients scheduled for catheter ablation
of drug refractory persistent AF or for catheter reablation
of AF recurrence after PVI for paroxysmal AF were eli-
gible for study participation because of needed additional
substrate modification. We excluded patients for the follow-
ing reasons: left atrial thrombus, symptomatic mitral valve
stenosis or moderate to severe mitral valve insufficiency (≥
grade 2 of 4), severely impaired left ventricular function
(left ventricular ejection fraction ≤35%), hyperthyroidism,
current pregnancy, and age <18 years or > 80 years. All
patients provided written informed consent. The ethics
committee at the Ludwig-Maximilians University, Munich,
Germany, approved the study, which was also registered at
www.clinicaltrials.gov (NCT02217657).
After written informed consent, through an investiga-
tor not involved in the ablation procedure, all enrolled
patients received a wide area circumferential PVI and were
intraprocedurally randomized in a 1:1 fashion to receive a left
atrial anterior line either with or without real-time display
of catheter tip-to-tissue contact force sensing information to
the investigator. Randomization was undertaken using sealed
envelopes. Figure 1 summarizes the study procedures.
Our primary endpoint was the radiofrequency time to
achieve bidirectional block of LA anterior line. Secondary
endpoints were procedural duration, fluoroscopy time, and
radiation dose and differences in contact force measures
between both groups. We further visually assessed LA ante-
rior line lesion formation by cMRI. Over the follow-up
duration of 12 months, we also compared the occurrence
of adverse events and the postprocedural atrial arrhythmia
recurrence rate.
2.2. Ablation Procedure. Patients were kept on continuous
oral anticoagulation, aiming for an international normalized
ratio (INR) of 2.0-2.7. For patients using Dabigatran, Apix-
aban, or Rivaroxaban, the last dose was paused. Ablation
procedures were performed under conscious sedation with
midazolam and remifentanil. For electroanatomical mapping
and three-dimensional navigation, we used the Carto 3 map-
ping system (BiosenseWebster Inc., DiamondBar, CA,USA).
A 10-electrode deflectable catheter was placed in the coronary
sinus (Inquiry, St. JudeMedical, LLC, St. Paul,MN,USA), and
the aortic root wasmarked using a pigtail catheter introduced
via the radial artery. The LA was accessed by single or double
transseptal puncture via a steerable sheath (Agilis, St. Jude
Medical, LLC, St. Paul, MN, USA). A fluoroscopic angiogram
of all pulmonary veins was performed prior to the ablation.
During the LA procedure time, intensified anticoagulation
was maintained with unfractionated heparin aiming for an
activated clotting time of ≥300 seconds.
For PVI, a steerable 20 electrode circular mapping
catheter (Lasso, Biosense Webster Inc., Diamond Bar, CA,
USA) was placed inside the pulmonary veins via the steerable
sheath. Radiofrequency (RF) ablation was then performed
using an open irrigated tip ablation catheter with contact
force sensing capabilities (Smart Touch, Biosense Webster
Inc., Diamond Bar, CA, USA), mostly without usage of a
sheath. Catheter settings were as follows: 30 watts, power
controlled with a temperature maximum of 43∘ Celsius, and
an irrigation rate of 30ml/min. We aimed for an ipsilateral
wide antral circumferential isolation of all pulmonary veins
in all patients regardless if PVI was performed previously. RF
lesions were done using the dragging method between abla-
tion points. Main target for individual lesion was electrogram
diminution with a contact force above 10 g. Pulmonary vein
isolation was confirmed by documentation of entrance and
exit block interpreting the bipolar electrograms of the circular
mapping catheter.
Following successful PVI, all patients received a LA
anterior line, depending on randomization using visible or
blinded contact force sensing information, since 10/2013
Visitag was available and not displayed in the blinded group.
The LA anterior line was formed using the same RF ablation
catheter as for PVI, connecting the anterior mitral annulus
with the left superior pulmonary. LA anterior line formation
was considered successful by documentation of bidirectional
block using differential pacing criteria and by documentation
of double potentials along the line [3, 8]. In the group with
contact force displayed, real-time contact force was visible
throughout the procedure, and investigators aimed for 10-30g
[9]. In the contact force blinded group, investigators relied on
standard criteria for ablation guidance. No other line apart
from LA anterior line was performed.
After a waiting period of 30 minutes after successful
formation of the LA anterior line, PVI isolation was recon-
firmed including fractionated application of intravenous
adenosine for each PV to rule out dormant conduction [10].
At the LA anterior line, bidirectional conduction block was
reconfirmed.
2.3. Cardiac Magnetic Resonance Imaging. cMRI was per-
formed with a 3-Tesla system (Magnetom Verio, Siemens
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Figure 1: Study flowchart. Ext CV: external cardioversion; AF: atrial fibrillation; cMRI: cardiac magnet resonance imaging; LA: left atrium;
CF: contact force; PVI: pulmonary vein isolation.
Healthineers, Erlangen, Germany). A first cMRI was per-
formed prior to the ablation procedure to visualize preex-
isting scar tissue in the ablation region. To improve image
quality, patients in AF underwent external cardioversion
prior to the scan. A second cMRI was scheduled three to six
months after the ablation for visualization of the anterior line.
Methodologically, fast low angle shot-inversion recov-
ery sequences (FLASH-IR) were performed 15 minutes
after contrast agent application (Gadobutrol 0.15mmol/kgbw,
Gadovist, BayerSchering, Berlin, Germany) (ST=0,9mm,
TE=1.460ms, TR=462.560ms, FA=20∘) for analysis of abla-
tion lesions by late gadolinium enhancement (LGE). Two
investigators blinded to randomization status and clinical
parameters independently assessed the LA anterior line visu-
ally comparing both available cMRI scans using the Siemens
Argus Software (Siemens Healthineers, Erlangen, Germany).
In case of discrepancies, a final judgment was reached by
consent. LA anterior line assessment was standardized by
defining three distinct line segments that were assessed
individually: (a) anterior mitral valve annulus to inferior
left atrial appendage; (b) septal of the left atrial appendage;
(c) roof of the left atrial appendage to the left superior
pulmonary vein (Figure 3).The same segment based analysis
was performed for the secondary analysis of locally applied
contact force data.
2.4. Follow-Up. Systematic follow-up was scheduled at the
arrhythmia clinic 3, 6, and 12 months after the ablation
procedure and done through physicians who were not part
of the ablation team and were blinded to treatment group. At
each visit, arrhythmia-related symptoms and adverse events
were surveyed. A 7-day Holter-ECG was obtained at each
visit. For AF recurrence analysis, we considered a blanking
period of 3 months. After this period, AF recurrence was
defined as any documented atrial arrhythmia of ≥30 second’s
duration. [1] Because the subgroup of patients with repeat
ablation due to relapse of paroxysmal AF was too small,
only patients with persistent AF and first ablation procedure
were analyzed regarding sinus rhythm after 12 months. Oral
anticoagulation was discontinued in patients without AF
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Table 1: Baseline characteristics.
Contact force information visible Contact force information blinded P value
Age (years) 66±9 62±9 0.06
Sex (male) 24 (65%) 25 (71%) 0.62
AF duration (years) 4.8±3.1 3.7±3.7 0.21
Persistent AF 28 (78%) 32 (91%) 0.19
LA diameter (mm) 43.6±5 43.8±5 0.85
EHRA Score (mean) 2.3±0.9 2.2±0.9 0.87
CHADS Vasc Score (mean) 2.2±1.0 2.2±1.6 0.99
HAS Bled Score (mean) 1.4±0.7 1.1±0.8 0.2
Arterial hypertension (%) 22 (66%) 21 (60%) 0.8
Vascular disease (%) 6 (18%) 7 (20%) 1.0
Heart failure (%) 4 (12%) 6 (17%) 0.47
Previous stroke (%) 2 (6%) 6 (17%) 0.26
Diabetes (%) 2 (6%) 2 (6%) 1.0
Data are mean±standard deviation or frequency (percentage). LA: left atrial; EHRA: European Heart Rhythm Association.
recurrence after 6 months in case of a CHA
2
DS
2
-VASc score
<2.
2.5. Statistical Analysis. We based our power calculation on
the experience of a previous study [3]. We assumed a RF
application time of 17 minutes for LA anterior line formation
without information on contact force. With contact force
information available, we expected a 40% reduction of RF
application time (10 minutes) [11]. Aiming for a two-sided
𝛼 of 5% and a power of 80%, we calculated a sample size of
62 patients (31 patients per group). To account for a primary
success rate of LA anterior line conduction block of 86%,
we planned our study to enroll 72 patients (36 patients per
group).
Statistical analysis was performed using SPSS (version 24,
IBM SPSS Statistics, IBM Corp, Amonk, NY) and R studio
(R foundation for statistical computing, Vienna Austria).
Continuous variables are presented as mean ± standard
deviation and are compared using the Wilcoxon rank sum or
Student’s t-tests. Categorical data are presented as frequency
and percentages and are analyzed using the chi-square or
Fisher exact tests. In addition, we fitted linear regression
models to account for potential confounding by age, sex,
and CHA2DS2-VASc score. P values <0.05 were considered
statistically significant.
3. Results
3.1. Patient Characteristics. Between 2012 and 2015, 72
patients were prospectively randomized and included in the
analysis. No significant differences in baseline characteristics
were noted between both study groups (Table 1).
3.2. Procedural Results. All patients received PVI and addi-
tional ablation of a LA anterior line as planned and according
to randomization status. PVIwas procedurally successfully in
all patients (100%). In 70 of 72 patients (97%), a bidirectional
block of the LA anterior line was achieved. The primary
endpoint being radiofrequency time to achieve bidirectional
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Figure 2:The primary endpoint of time to bidirectional block of the
LA anterior line did not differ between both groups.
block at the LA anterior line did not differ significantly
(p=0.50) between both groups with 23±18min (contact force
information visible) versus 21±15min (contact force informa-
tion blinded) (Table 2; Figure 2).
In addition, secondary endpoints did not differ signif-
icantly between both groups: overall procedure time (con-
tact force information visible: 192.6±30min versus contact
force information blinded: 189±60min, p=0.70); overall
fluoroscopy time (23.3±10min versus 27.9±13min, p=0.12);
overall radiation dose (1930±2025 cGy∗cm2 versus 1692±1128
cGy∗cm2, p=0.57). Details are provided in Table 2.
Analysis of contact force information and force time
integral at the LA anterior line by prespecified line segments
similarly revealed no significant differences between both
groups (Figure 3). Across line segments, contact force >10g
was achieved in 80% of applied lesions.
Six patients (16%) in the visible group and six patients
(17%) in the blinded group showed a reconnected LA anterior
line after the waiting period and were successfully reablated
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Table 2: Procedural data.
Contact force information visible Contact force information blinded P value
Procedure time (min) 192.6±30 189±60 0.7
Total fluoroscopic time (min) 23.3±10 27.9±13 0.12
LA anterior line fluoroscopy time (min) 1.1±1.2 0.8±1.1 0.3
Radiation dose (cGy∗cm2) 1930±2025 1692±1128 0.57
Time to complete LA anterior line (min) 23 ±18 21±15 0.5
LA anterior line reconnection during waiting period 6 (16%) 6 (17%) 0.9
LA anterior line RF applications (n) 10±7 10.4±11 0.9
Data are mean±standard deviation. LA: left atrial; RF: radiofrequency.
Contact information visible
FTI 3296±2610g∗s 
FTI 5345±3975g∗s 
LSPV Contact information blinded
CF 12.0±5g 
CF 12.0±5g 
p = 0.31
p = 0.07
p = 0.54
LAA
CF 10.7±5g FTI 2655±2678g∗sFTI 2078±2086g∗s 
Mitral valve
CF 14.1±7g
CF 14.3±7g
CF 14.7±9±8g
FTI 4575±3401g∗s
FTI 2993±2596g∗s
Figure 3: Distribution of contact force and force time integral in different segments of the anterior line. LAA: left atrial appendage; CF:
contact force; FTI: force time integral; LSPV: left superior pulmonary vein. No significant difference could be detected between groups.
showing no significant difference between both groups.
Patients with reconnection compared to patients without
showed no significant difference in applied contact force
(13.1±4g versus 13.6±6g respectively, p = 0.8).
The secondary endpoint comparing contact force in three
distinct segments of the LA anterior line did not reveal
significant differences across randomization groups: LSPV,
left superior pulmonary vein; LAA, left atrial appendage; CF,
contact force (Figure 3).
Multivariable adjusted analyses suggested no confound-
ing by cMRI derived end-diastolic or end-systolic left ven-
tricular volume, LA ejection fraction (cMRI), left ventricular
ejection fraction (echocardiography), and ablation in sinus-
rhythm or AF.
3.3. MRI Results. In 49 patients, both the cMRI acquired at
baseline and at follow-up showed sufficient image quality for
analysis. The remaining patients were not suitable for analysis
due to insufficient image quality (n=8), incident pacemaker
implantation after the baseline scan (n=4), and withdrawal of
consent for the follow-up cMRI (n=11).
In the initial cMRI, LGE at the anteriorwall was present in
six patients (15%) without a difference between both groups
(p=0.19). LGE before ablation procedure did not influence
time to achieve bidirectional block of anterior line and did
not influence outcome after 12-month follow-up. After the
ablation, the LA anterior line was visible on cMRI in at
least one segment in 40 patients (82%), regardless of whether
contact force was displayed or not (p=0.46). Restricting
the analysis to those patients with visible LA anterior line
on cMRI, we similarly found no significant differences in
contact force between randomization groups (contact force
information visible: 12.9±4g versus contact force information
blinded: 11.6±1.8g, p=0.42) (Figure 3).
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In 26 patients (53%), which underwent a post-cMRI, a
complete LA anterior line was detected by cMRI in all three
segments, with no difference between both groups (p=0.78).
In addition, no significant differences regarding contact force
could be detected (contact force information visible: 14±7g
versus contact force information blinded: 12.7±3g, p=0.31).
Segment-specific analysis revealed that the LA anterior line
was visible in 66% of patients between the anterior mitral
annulus and the left atrial appendage, in 61% of patients septal
of the left atrial appendage, and in 75% of patients between
the left atrial appendage and the left superior pulmonary
vein. For neither of the segments did we identify signifi-
cant differences in contact force: contact force information
visible: 14.7±9g, 14.3±7g, and 14.1±7g, respectively, versus
10.7±5g, 13.2±5g, and 12.0±5g, respectively; p=0.07, p=0.54,
and p=0.31, respectively. Multivariable adjustment did not
relevantly change these results.
3.4. Follow-Up at 12 Months and Repeat Ablation Procedures.
Follow-up at 12 months was available for 71 (99%) patients,
with one patient lost to follow-up. The recurrence rate of any
documented atrial arrhythmia in patients with persistent AF
off any antiarrhythmic class I or class III medication was 45%
(contact force information visible) versus 52% (contact force
information blinded) after a single procedure (p=0.8).
Overall, 17 patients underwent repeat ablation, equivalent
to 23% of patients in the contact force information visible
group and 29% of patients in the contact force informa-
tion blinded group (p=0.8). The rates of left atrial flutter
(contact force information visible: 37% versus contact force
information blinded: 44%, p=0.16) and the percentages of
sustained bidirectional block of the LA anterior line during
the repeat procedure (contact force information visible: 37%
versus contact force information blinded: 44%, p=0.1) did
not differ significantly. In 10 of 17 patients with repeat
ablation cMRI was available. Of these, eight patients showed
a reconnected LA anterior line during the repeat procedure.
In this subgroup, LA anterior line was visible on cMRI in
all segments in 3 (37%) patients and was not visible in all
segments in 5 (63%) patients showing no statistical difference
between groups (p = 1.0).
3.5. Adverse Events. Acute adverse events during the index
hospitalization occurred in four patients (5%). One patient
developed cardiac tamponade requiring pericardiocentesis
in the contact force information blinded group and could
be discharged without any further problems. In this patient,
no excessive contact force was recorded. In two patients
(one per group), groin vascular access site pseudoaneurysms
were treated without necessity for surgical intervention.
One patient in the contact force information blinded group
developed a groin AV-fistula, which resolved without surgical
intervention. No significant difference in adverse event rates
was noted between both groups (p=0.61).
4. Discussion
In this prospective, randomized clinical trial of patients
undergoing PVI for AF, display of contact force information
during the application of an additional LA anterior line did
not reduce the radiofrequency time to achieve bidirectional
block of the line. In addition, contact force, procedural
measures, visibility of the LA anterior line on cMRI, and
the AF ablation outcome after 12 months of follow-up were
similar between both groups.
4.1. Contact Force during Linear Ablation. In this study, 72
patients were randomized to application of a LA anterior
line either with or without the display of contact force
information. In all patients, the same ablation catheters
and mapping systems were used. The primary endpoint of
time to bidirectional block of the LA anterior line, as well
as various secondary endpoints, did not differ significantly
between groups. Until now, no study addressing the efficacy
and effectiveness of contact force information on LA linear
ablations was available. Prior studies using conventional
ablation catheters achieved bidirectional block of LA anterior
lines in only 60% to 86% [2, 3]. We thus hypothesized that
information on contact force could improve the time to
achieve bidirectional block of the LA anterior, but failed to
identify significant differences. However, our rate of achieved
bidirectional block (97%) was much higher than previ-
ously reported using conventional ablation catheters. Possible
explanations may include longer investigator experience in
LA line ablation compared to early reports with limited
experience, as well as improvements in ablation catheter
technology, even without information on contact force.
Inmultiple studies, use of contact force for PVI has shown
a reduction of acute pulmonary vein reconnection [12–14].
However, in most studies either no randomized protocol was
used, or the contact force sensing catheter was compared to a
different catheter without contact force sensing capability.
Similar to our study, Ullah et al. randomized 117 patients
undergoing PVIwith orwithout information on contact force
using the same ablation catheter (Smart-Touch, Biosense
Webster) [6].The primary endpoint was time to achieve com-
plete PVI. In their study, time to achieve PVI, procedure time,
and fluoroscopic data did not differ significantly between
both groups; in addition, mean contact force was identical
in both groups with 13.4g. However, time in contact force
target range (5-40g) was significantly higher (80% versus
68%, p<0.001) and the rate of acute PV reconnection was
significantly lower (22% versus 32%, p=0.03) in those with
versus those without display of contact force data. This is
partly in line with our data, where mean contact force and
force time integral were comparable between both groups.
However, in our cohort, 80% of ablation points reached a
target contact force ≥10g, irrespective of randomization. A
possible explanation might be different anatomical reachabil-
ity of the pulmonary veins compared to the LA anterior wall.
4.2. Visibility of the Anterior Line on cMRI. Patients under-
went cMRI shortly before and three to six months after
ablation with the aim of visualizing the LA anterior line [15]
and to associate it with the applied contact force. In 81%
of cMRIs after ablation, the LA anterior line was visible in
at least one segment. However, a visible line in all three
segments could only be detected in 52% of patients. This
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contrasts a bidirectional electrical block that was achievable
in 92% of patients. Similarly in a prior study, ablation lines
could only be recognized in 54% of patients using cMRI with
late gadolinium enhancement [16]. In our cohort, patients
without visible lines in all three segments did not show a
lower contact force compared to patients with a visible line.
This is in contrast to Andreu et al., where gaps in the ablation
lines around the pulmonary veins correlated with reduced
contact force (6.7 versus 12.2g) in 36 patients [17]. As in
our cohort, 80% of ablation points had a contact force ≥10g.
Radiofrequency applications with low contact force at the
anterior wall were few and a significant difference might
have been missed. However, other studies were not able to
substantiate a clear correlation between ablation gaps and
scar tissue on cMRI either [18]. Such heterogeneity implies
that cMRI image acquisition and postprocessing are variable
across studies, and further efforts are required to standardize
and harmonize cMRI protocols for future studies and to
improve lesion imaging.
4.3. Success at 12-Month Follow-Up. After systematic 12-month
follow-up including repetitive 7-day Holter-monitoring and
detailed questioning, we did not find a significant difference
in AF recurrence and single procedure success between both
groups. This is in line with existing work, where the use of
contact force did not improve the rate of sinus rhythm after
midterm follow-up [6, 12, 13, 19]. Also, a 1-year success rate of
about 50% in patients undergoing ablation for persistent AF
appears to be comparable to others [10]. New technologies
like ablation index [20] and use of higher contact fore or the
use of high power ablation might improve ablation outcome.
However, prospective randomized trials on this subject are
still under way.
5. Limitations
Our results clearly show no relevant differences between our
study groups randomized to LA anterior line ablation with
or without display of contact force information. It appears
unlikely that a larger cohort would have relevantly changed
our results. However, we submit that we did not observe
the anticipated difference in procedure time that was the
basis for our power calculation. It is thus possible that we
have missed significant differences due to a lack of statistical
power. Complete cMRI data before and after the ablation
procedurewas only available in 50 patients with no difference
between both groups (visible group: 24 versus blinded group:
26, p = 0.45). This might have further reduced our statistical
power for cMRI specific analyses. In most of the procedures,
we did not use a deflectable sheath for the ablation catheter;
perhaps this would have improved the efficacy of the linear
ablation. However, 97% of bidirectional block is higher than
previously published.
6. Conclusion
In this prospective randomized clinical trial, information
on contact force during the ablation of a LA anterior line
did not reduce radiofrequency time to achieve bidirectional
line block. In addition, other procedural data as well as
the ablation success rate after 12 months of follow-up did
not reveal significant differences between both groups. By
cMRI, LA anterior line visibility did not significantly correlate
with the applied contact force. In conclusion, information
on contact force does not seem to improve procedural
and overall ablation success with respect to LA anterior
line ablation. In addition, creating anterior line as the only
additional lesion in patients with persistent AF in the attempt
to improve the success rate of the procedure is still disputable
and, therefore, it just remains a partial technique, due to the
complexity of the pathophysiology of persistent AF.
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